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Antibody drugs are a rapidly growing set of therapeutics that increasingly prove effective for clinical applications 
spanning from macular degeneration treatments, to targeted cancer therapies, and to passive immunization. 
These antibody treatments can be engineered to target almost any cell surface moiety and their production has 
since been scaled to an industrial level. Despite these advances, parenteral administration of antibodies is 
severely constrained by high viscosities at desirable doses, poor long-term antibody stability, high required 
frequency of administration, and therapeutically suboptimal pharmacokinetics. Herein, we demonstrate the 
development of supramolecular polymer-nanoparticle (PNP) interactions between poly(ethylene glycol)-
poly(lactic acid) block copolymer nanoparticles (PEG-PLA) and modified hydroxypropylmethylcellulose (HPMC-
x) polymers to engineer shear-thinning, self-healing hydrogels capable of stabilizing and delivering high 
concentrations of antibodies over prolonged timeframes (Figure 1). The PNP interactions underpinning the 
behavior of these materials afford injectability and tunable mechanical properties, while also controlling antibody 
release kinetics. In this work, we investigate how the thermodynamics of the PNP interaction affect in vitro and 
in vivo antibody release kinetics, pharmacokinetics, and bioavailability. Analysis of PEG-PLA surface density, 
HPMC-x hydrophobicity and modification extent, and hydrogel formulation reveal explicit design handles relating 
PNP thermodynamics to in vivo antibody release kinetics via subcutaneous injection. Differences in antibody 
release kinetics between in vitro and in vivo experiments were examined through mathematical modelling, 
revealing possible mechanisms of antibody uptake from subcutaneous space to the bloodstream when 
compared to literature. Overall, this work presents a robust set of design parameters to tune PNP interactions to 





Figure 1 – (A) In vitro experiments characterizing the delivery of a model drug, which exhibits distinct release 
profiles depending on functional group attached to HPMC. These functional groups exhibited varying interaction 
strengths with PEG-PLA nanoparticles and formed gels with different mechanical and antibody release 
properties. (B) Serum concentration of anti-OVA antibodies delivered from a hydrogel formulation after 
subcutaneous injection into C57BL6 mice. The dotted line represents a pharmacokinetic (PK) model that 
accounts for kinetics of antibody release from the hydrogel, uptake into the bloodstream via subcutaneous 
space, and decay from the bloodstream. 
